214 related articles for article (PubMed ID: 10860852)
1. VIP activates G(s) and G(i3) in rat alveolar macrophages and G(s) in HEK293 cells transfected with the human VPAC(1) receptor.
Shreeve SM; Sreedharan SP; Hacker MP; Gannon DE; Morgan MJ
Biochem Biophys Res Commun; 2000 Jun; 272(3):922-8. PubMed ID: 10860852
[TBL] [Abstract][Full Text] [Related]
2. Identification of G-proteins coupling to the vasoactive intestinal peptide receptor VPAC(1) using immunoaffinity chromatography: evidence for precoupling.
Martin Shreeve S
Biochem Biophys Res Commun; 2002 Feb; 290(4):1300-7. PubMed ID: 11812005
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
Diehl NL; Kermode JC; Shreeve SM
Mol Pharmacol; 1996 Sep; 50(3):624-30. PubMed ID: 8794903
[TBL] [Abstract][Full Text] [Related]
4. Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion.
Meneray MA; Fields TY; Bennett DJ
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1261-70. PubMed ID: 9152245
[TBL] [Abstract][Full Text] [Related]
5. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
Nachtergael I; Vertongen P; Langer I; Perret J; Robberecht P; Waelbroeck M
Biochem J; 2003 Mar; 370(Pt 3):1003-9. PubMed ID: 12475394
[TBL] [Abstract][Full Text] [Related]
7. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
El Zein N; Badran B; Sariban E
Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and functional expression of a VIP-specific receptor.
Zhou H; Huang J; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G728-34. PubMed ID: 16959956
[TBL] [Abstract][Full Text] [Related]
9. Identification of G proteins in lacrimal gland.
Meneray MA; Bennett DJ
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1173-80. PubMed ID: 7730026
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
Van Rampelbergh J; Juarranz MG; Perret J; Bondue A; Solano RM; Delporte C; De Neef P; Robberecht P; Waelbroeck M
Br J Pharmacol; 2000 Jun; 130(4):819-26. PubMed ID: 10864888
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.
Vertongen P; Solano RM; Perret J; Langer I; Robberecht P; Waelbroeck M
Br J Pharmacol; 2001 Aug; 133(8):1249-54. PubMed ID: 11498510
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
14. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
Vertongen P; Langlet C; Langer I; Gaspard N; Robberecht P
Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
[TBL] [Abstract][Full Text] [Related]
15. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
[TBL] [Abstract][Full Text] [Related]
16. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
Fukuchi M; Sakuragawa S; Tabuchi A; Tsuda M
J Neurosci Res; 2004 Jul; 77(1):26-34. PubMed ID: 15197736
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding.
Nicole P; Maoret JJ; Couvineau A; Momany FA; Laburthe M
Biochem Biophys Res Commun; 2000 Sep; 276(2):654-9. PubMed ID: 11027527
[TBL] [Abstract][Full Text] [Related]
18. The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes.
Pineau N; Lelievre V; Goursaud S; Hilairet S; Waschek JA; Janet T; Muller JM
Neuropeptides; 2001 Apr; 35(2):117-26. PubMed ID: 11384207
[TBL] [Abstract][Full Text] [Related]
19. Vip-induced cross-talk between G-proteins in membranes from rat anterior pituitary cells.
Cussac D; Kordon C; Enjalbert A; Saltarelli D
Cell Signal; 1993 Mar; 5(2):119-37. PubMed ID: 8499223
[TBL] [Abstract][Full Text] [Related]
20. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components.
Hodges RR; Zoukhri D; Sergheraert C; Zieske JD; Dartt DA
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):610-9. PubMed ID: 9071214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
